top of page

RM Global BioAccess Fund

News

Apr 23, 2025

Treating Autoimmune Diseases: Four New Technologies To Watch (Forbes)

Apr 7, 2025

Who should we be watching on the USA biotech stage? (DDW-Online)

Apr 7, 2025

Epsilogen Announces Acquisition of TigaTx, Inc. to Create World’s Leading Pan-Isotype Cancer Antibody Company (Epsilogen)

Mar 21, 2025

The most funded women-led life sciences companies in the Bay Area in 2024 (bizjournals.com)

Dec 19, 2024

TigaTx Announces up to $35.5M in Funding from ARPA-H and NIH Awards to Advance First-in-Class Engineered IgA Monoclonal Antibody for Cancer and Infectious Diseases (biospace.com)

Dec 5, 2024

Nuvig Therapeutics Announces $161 Million Series B Financing and Progression to Phase 2 Development with Novel, Second-Generation Immunomodulator (businesswire.com)

Nov 12, 2024

Vittoria Biotherapeutics Completes $25 Million in Private Financing to Propel Groundbreaking Cell Therapy Candidates (globalnewswire.com)

Oct 9, 2024

ShiraTronics Raises $66 Million in Oversubscribed Series B Financing to Advance Pioneering Treatment for Chronic Migraine (prnewswire.com)

Sep 27, 2024

Odyssey Therapeutics Announces Formation of Scientific Advisory Board (businesswire.com)

Sep 26, 2023

Acesion clinches $47M in Series B raise to advance preclinical cardiac arrhythmia candidate through PhII (endpts.com)

Sep 7, 2021

RMG-KB BIOACCESS FUND LAUNCHES with Worldwide Focus on Innovative Life Sciences Ventures (prnewswire.com)

bottom of page